Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1990-6-14
|
pubmed:abstractText |
It has been previously recognized that a number of protocols may cause breakage of the triad junction and separation of the constituent organelles of skeletal muscle. We now describe a fraction of triad junctions which is refractory to the known protocols for disruption. Triads were passed through a French press and the dissociated organelles were separated on a sucrose density gradient, which was assayed for PN200-110, ouabain and ryanodine binding. Ryanodine binding showed a single peak at the density of heavy terminal cisternae. On the other hand, the PN200-110 and ouabain, which are external membrane ligands, bound in two peaks: one at the free transverse tubule region and the other at the light terminal cisternae. Similarly, a two peak pattern of PN200-110 and ouabain binding was observed when triad junctions were broken by the Ca2(+)-dependent protease, calpain, which selectively hydrolyzes the junctional foot protein. The light terminal cisternae vesicles were subjected to three different procedures of junctional breakage: French press, hypertonic salt treatment, and protease digestion using calpain or trypsin. The treated membranes were then centrifuged on density gradients. Only extensive trypsin digestion caused a partial shift of ouabain activity into the free transverse tubule region. These observations suggest that the triads are a composite mixture of breakage susceptible, "weak," and breakage resistant, "strong," triads. Scatchard analysis of PN200-110 suggests that the transverse tubules of strong triads contain a relatively high number of dihydropyridine receptors compared to those of weak triads. Thin section electron microscopic images of the strong triads comparable to those of intact muscle are presented.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channels,
http://linkedlifedata.com/resource/pubmed/chemical/Isradipine,
http://linkedlifedata.com/resource/pubmed/chemical/Oxadiazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cholinergic,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Nicotinic,
http://linkedlifedata.com/resource/pubmed/chemical/Ryanodine Receptor Calcium Release...,
http://linkedlifedata.com/resource/pubmed/chemical/Trypsin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-2631
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
113
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
221-35
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2159516-Animals,
pubmed-meshheading:2159516-Calcium Channel Blockers,
pubmed-meshheading:2159516-Calcium Channels,
pubmed-meshheading:2159516-Cell Fractionation,
pubmed-meshheading:2159516-Isradipine,
pubmed-meshheading:2159516-Kinetics,
pubmed-meshheading:2159516-Microscopy, Electron,
pubmed-meshheading:2159516-Microsomes,
pubmed-meshheading:2159516-Muscles,
pubmed-meshheading:2159516-Organelles,
pubmed-meshheading:2159516-Oxadiazoles,
pubmed-meshheading:2159516-Rabbits,
pubmed-meshheading:2159516-Receptors, Cholinergic,
pubmed-meshheading:2159516-Receptors, Nicotinic,
pubmed-meshheading:2159516-Ryanodine Receptor Calcium Release Channel,
pubmed-meshheading:2159516-Subcellular Fractions,
pubmed-meshheading:2159516-Trypsin
|
pubmed:year |
1990
|
pubmed:articleTitle |
Identification of a new subpopulation of triad junctions isolated from skeletal muscle; morphological correlations with intact muscle.
|
pubmed:affiliation |
Department of Pharmacology, University of Miami, School of Medicine, Florida 33101.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|